Insider buying last 90 days
No open-market insider purchases were filed for HTFL in the last 90 days.
From Form 4 filings, dated to when each was filed.
Nov 13 close
Heartflow's week centers on clinical data presented at major cardiology conferences, alongside a shifting analyst picture ahead of earnings. At TCT 2026, the company presented 12-month data showing its CT-guided PCI planning is non-inferior to intravascular ultrasound, with a 17-minute reduction in procedure time and a 12% decrease in contrast volume. Separately, data from the DECIDE registry, presented at AHA 2026, associated Heartflow's AI-powered plaque analysis with 34% fewer major cardiovascular events and half the rate of heart attack at one year versus CCTA alone. Wall Street Zen lowered its stock rating on HTFL, and options data point to a possible 17% move around the 12 November earnings report.
HTFL closes at $56.66, up 8.1%, sitting above both its 50-day ($51.46) and 200-day ($34.72) averages, with the shorter average above the longer one. The GekkoIndex reads 53.9, placing the stock in the Neutral zone, up 2.4 over five days. Price sits 11.2% above Gekko Fair Value of $50.97.
The next 20 trading days bring the earnings report on 12 November, just 2 days out, following a prior quarter where actual EPS of -1.46 missed estimates of -0.22 and the stock reacted with a 41% move; average absolute reaction across recent quarters runs 18.7%. Options data flag a potential 17% move around the report. No insider, Congress, or unusual options activity appears in their respective windows, though one billionaire holder and two trailblazer holders are recorded. Analyst consensus among 8 firms stands at 6 buy and 2 hold, with a consensus target of $50.50.
Written by AI from the Nov 9, 2026 close and checked automatically against the figures on this page.
Heartflow scores 2 supportive, 1 mixed and 0 headwinds across the 3 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
2 supportive1 mixed0 headwinds
Averages disagree
Close $48.46 sits between the 50-day ($51.91) and 200-day ($35.21) averages, or the averages disagree.
See the chart60.9, Accumulation
Reading 60.9 is in the Accumulation zone.
See the GekkoIndex6.7% below
Price is 6.7% below Gekko Fair Value (more than 5% below).
See fair valueNo data
No insider, Congress or unusual options activity in the window.
See smart moneyNo data
No confirmed report date on the calendar.
See earningsNo data
Not enough years of history for a seasonal read.
A description of current data, not a recommendation. How this page works
Heartflow closed at $48.46 on Nov 13, 2026, +35.6% over the past year, inside a 52-week range of $20.13 to $60.66.
Use the left and right arrow keys to read daily values.
Put HTFL on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Heartflow makes technology used to diagnose and manage coronary artery disease without surgery. Its core offering, the Heartflow Platform, uses artificial intelligence and computational fluid dynamics to build a three-dimensional digital model of a patient's heart from a single coronary CT angiography scan. The platform is best known for turning that one scan into detailed readings of blood flow, arterial narrowing, and plaque volume and makeup, addressing gaps left by conventional non-invasive imaging.
The company positions its platform as a tool for clinicians involved in heart disease diagnosis and ongoing patient care, built around the CCTA scan as its data source rather than requiring additional invasive procedures.
Heartflow was founded in 2007 and is headquartered in Mountain View, California. Its shares are listed on the NASDAQ under the ticker HTFL.
Heartflow’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 60.9, in the Accumulation zone, up 3.2 points over five sessions.
Up 3.2 points over five sessions, from the Neutral zone.
Reading for Nov 13, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 9 | Too few readings yet | |||
| Accumulation (current zone) | 89 | −0.3% | +16.3% | ||
| Neutral | 183 | +2.8% | +3.1% | ||
| Distribution | 22 | −6.2% | −6.0% | ||
| Selling | 7 | Too few readings yet | |||
Average HTFL share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Accumulation readings averaged +2.0% over 20 days. Past behaviour doesn’t guarantee future results.
Accumulation zone: Institutional interest building. About the five zones →
Heartflow trades 6.7% below Gekko Fair Value of $51.95, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Heartflow shares are worth, recalculated every trading day.
$51.95
Gekko Fair Value, Nov 14, 2026
6.7% Undervalued
At the end of Aug 2026 the price was 26.9% above the estimate.
No open-market insider purchases were filed for Heartflow, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
No open-market insider purchases were filed for HTFL in the last 90 days.
From Form 4 filings, dated to when each was filed.
No trades in HTFL were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Heartflow has been buying back its own shares.
From company filings.
2of the funds Gekko tracks hold HTFL.
Heartflow beat the EPS estimate in 2 of its last 5 reports, moving 18.7% on average across the report.
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Aug 13, 2026 | −$1.46 est −$0.22 | $64.08M est $56.64M | +41.0% |
| May 14, 2026 | −$0.16 est −$0.17 | $52.59M est $49.71M | −9.2% |
| Mar 18, 2026 | −$0.12 est −$0.15 | $49.13M est $46.58M | +15.0% |
| Nov 12, 2025 | −$0.27 est −$0.20 | $46.28M est $46.30M | −9.5% |
| Jul 17, 2025 | −$0.46 est −$0.21 | $37.20M est $43.20M | — |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for Heartflow is $52.00, +7.3% from the last close, from 8 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 8 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Nov 13 | Wells Fargo | $70 | +44.4% |
| Nov 13 | Stifel Nicolaus | $70 | +44.4% |
| Nov 13 | Robert W. Baird | $68 | +40.3% |
| Nov 13 | Piper Sandler | $64 | +32.1% |
| Nov 13 | Canaccord Genuity | $69 | +42.4% |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Heartflow’s market cap is $4.21B and revenue of $238.7M over the last twelve months.
Coverage of Heartflow this week reads neutral: 6 positive, 8 neutral and 0 negative headlines.
Heartflow’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| MSFTMicrosoft | Neutral | 10.6% above |
| PLTRPalantir Technologies | Accumulation | 8.2% below |
| ORCLOracle | Neutral | 27.9% below |
| PANWPalo Alto Networks | Accumulation | 0.6% above |
| CRWDCrowdStrike | Accumulation | 0.9% above |
| CRMSalesforce | Accumulation | 12.1% below |
A peer links to its own page where one exists.
Heartflow’s market cap is $4.21B at the Nov 13, 2026 close of $48.46, with 86.95M shares outstanding.
The consensus analyst 12-month price target for Heartflow is $52.00, +7.3% from the last close. Of the 8 firms that rated the stock in the last 90 days, 6 rate it a buy, 2 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate Heartflow is undervalued: the Nov 13, 2026 close of $48.46 is 6.7% below Gekko Fair Value of $51.95. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
Heartflow’s 52-week high is $60.66 and its 52-week low is $20.13; it closed at $48.46 on Nov 13, 2026, +35.6% over the past year.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 2 of the 3 items with data read as supportive (gekkoindex and fair value), 1 as mixed (trend). The checklist is a description of current data, not a recommendation.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,475 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.